Clinical Trial Update: Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid Response [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on managing ovarian hyperstimulation syndrome via defective mineralocorticoid response.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Hyperstimulation Syndrome

Snippet

Sponsor: Ganin Fertility Center | Conditions: Ovarian Hyperstimulation Syndrome | Phase 2 | Status: COMPLETED